Latest period
2.04B
YoY change
+0.7%
5Y CAGR
-2.0%
Peak year (2020)
2.26B
Latest annual
2.04B
Shares Outstanding history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: 2.04B
Shares Outstanding growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: +0.7%
Shares Outstanding history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| 2025 | 2.04B | +0.7% | +14.00M | ||
| 2024 | 2.03B | -2.5% | -51.00M | ||
| 2023 | 2.08B | -3.2% | -68.00M | ||
| 2022 | 2.15B | -4.4% | -99.00M | ||
| 2021 | 2.25B | -0.6% | -13.00M | ||
| 2020 | 2.26B | +31.9% | +546.00M | ||
| 2019 | 1.71B | +4.6% | +75.00M | ||
| 2018 | 1.64B | -0.9% | -15.00M | ||
| 2017 | 1.65B | -1.7% | -28.00M | ||
| 2016 | 1.68B | +0.1% | +1.00M | ||
| 2015 | 1.68B | +0.5% | +9.00M | ||
| 2014 | 1.67B | +0.5% | +8.00M | ||
| 2013 | 1.66B | -1.5% | -26.00M | ||
| 2012 | 1.69B | -1.7% | -29.00M | ||
| 2011 | 1.72B | -0.6% | -10.00M | ||
| 2010 | 1.73B | -12.7% | -251.00M | ||
| 2009 | 1.98B | -1.1% | -23.00M | ||
| 2008 | 2.00B | +1.1% | +21.00M | ||
| 2007 | 1.98B | +0.9% | +17.00M | ||
| 2006 | 1.96B | -1.0% | -20.00M | ||
| 2005 | 1.98B | +0.4% | +7.00M | ||
| 2004 | 1.98B | +1.3% | +26.00M | ||
| 2003 | 1.95B | -3.3% | -66.04M | ||
| 2002 | 2.02B | +2.6% | +51.04M | ||
| 2001 | 1.97B | -1.6% | -32.00M | ||
| 2000 | 2.00B | -1.5% | -30.00M | ||
| 1999 | 2.03B | -0.2% | -4.00M | ||
| 1998 | 2.03B | -0.5% | -11.00M | ||
| 1997 | 2.04B | +0.3% | +6.00M | ||
| 1996 | 2.04B | +0.2% | +4.00M | ||
| 1995 | 2.03B | -0.2% | -4.00M | ||
| 1994 | 2.04B | -1.3% | -26.11M | ||
| 1993 | 2.06B | +0.9% | +18.36M | ||
| 1992 | 2.04B | -1.6% | -33.02M | ||
| 1991 | 2.08B | -0.2% | -4.18M | ||
| 1990 | 2.08B | +0.3% | +5.95M | ||
| 1989 | 2.08B | -0.7% | -15.00M | ||
| 1988 | 2.09B | -2.2% | -46.00M | ||
| 1987 | 2.14B | — | — |
- 20252.04B+0.7%
- 20242.03B-2.5%
- 20232.08B-3.2%
- 20222.15B-4.4%
- 20212.25B-0.6%
- 20202.26B+31.9%
- 20191.71B+4.6%
- 20181.64B-0.9%
- 20171.65B-1.7%
- 20161.68B+0.1%
- 20151.68B+0.5%
- 20141.67B+0.5%
- 20131.66B-1.5%
- 20121.69B-1.7%
- 20111.72B-0.6%
- 20101.73B-12.7%
- 20091.98B-1.1%
- 20082.00B+1.1%
- 20071.98B+0.9%
- 20061.96B-1.0%
- 20051.98B+0.4%
- 20041.98B+1.3%
- 20031.95B-3.3%
- 20022.02B+2.6%
- 20011.97B-1.6%
- 20002.00B-1.5%
- 19992.03B-0.2%
- 19982.03B-0.5%
- 19972.04B+0.3%
- 19962.04B+0.2%
- 19952.03B-0.2%
- 19942.04B-1.3%
- 19932.06B+0.9%
- 19922.04B-1.6%
- 19912.08B-0.2%
- 19902.08B+0.3%
- 19892.08B-0.7%
- 19882.09B-2.2%
- 19872.14B—
Shares Outstanding values are taken from Bristol-Myers Squibb's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported diluted shares outstanding is 2.04B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Bristol-Myers Squibb (BMY) most recent annual diluted shares outstanding stands at 2.04B (2025) – edged up 0.7% year-over-year.
Bristol-Myers Squibb diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -2.0%, with a net decline across the window.
Bristol-Myers Squibb diluted shares outstanding declined from 2.26B in 2020 to 2.04B in 2025, a 9.6% drawdown.
The highest annual diluted shares outstanding of 2.26B was reported in 2020. The lowest in the available history was 1.64B in 2018.
Bristol-Myers Squibb Shares Outstanding by Year
Bristol-Myers Squibb Shares Outstanding 2025: 2.04B
Bristol-Myers Squibb diluted shares outstanding in 2025 was 2.04B, edged up 0.7% from 2024.
Bristol-Myers Squibb Shares Outstanding 2024: 2.03B
2024's diluted shares outstanding for Bristol-Myers Squibb came in at 2.03B, edged down 2.5% below 2023.
Bristol-Myers Squibb Shares Outstanding 2023: 2.08B
Bristol-Myers Squibb posted diluted shares outstanding of 2.08B in 2023, edged down 3.2% below 2022.
Bristol-Myers Squibb Shares Outstanding 2022: 2.15B
In 2022, Bristol-Myers Squibb reported diluted shares outstanding of 2.15B, edged down 4.4% below 2021.
Bristol-Myers Squibb Shares Outstanding 2021: 2.25B
Bristol-Myers Squibb diluted shares outstanding in 2021 was 2.25B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Shares Outstanding
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation